LSA
VIR icon

Leonteq Securities AG’s Vir Biotechnology VIR Stock Holding History

Leonteq Securities AG’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$204K Buy
+20,000
New +$190K 0.01% 566
2025
Q3 		– Sell
-2,700
Closed -$13.6K – 1389
2025
Q2 		$13.6K Hold
2,700
– – ﹤0.01% 1027
2025
Q1 		$17.5K Sell
2,700
-800
-23% -$7.11K ﹤0.01% 1002
2024
Q4 		$25.7K Hold
3,500
– – ﹤0.01% 934
2024
Q3 		$26.2K Hold
3,500
– – ﹤0.01% 875
2024
Q2 		$31.1K Hold
3,500
– – ﹤0.01% 856
2024
Q1 		$35.5K Sell
3,500
-8,429
-71% -$85.8K ﹤0.01% 830
2023
Q4 		$120K Sell
11,929
-32,204
-73% -$294K 0.01% 604
2023
Q3 		$414K Buy
44,133
+6,668
+18% +$95.1K 0.02% 376
2023
Q2 		$919K Sell
37,465
-26,407
-41% -$663K 0.05% 293
2023
Q1 		$1.49M Buy
63,872
+62,372
+4,158% +$1.6M 0.07% 228
2022
Q4 		$38K Hold
1,500
– – ﹤0.01% 874
2022
Q3 		$28.9K Sell
1,500
-200
-12% -$5.08K ﹤0.01% 913
2022
Q2 		$43.3K Sell
1,700
-300
-15% -$7K ﹤0.01% 854
2022
Q1 		$51.4K Buy
2,000
+1,850
+1,233% +$54.9K ﹤0.01% 855
2021
Q4 		$6.28K Sell
150
-50
-25% -$1.96K ﹤0.01% 1183
2021
Q3 		$8.7K Buy
200
+85
+74% +$3.68K ﹤0.01% 1057
2021
Q2 		$5.44K Sell
115
-5,016
-98% -$228K ﹤0.01% 1020
2021
Q1 		$263K Sell
5,131
-7
-0.1% -$377 0.02% 505
2020
Q4 		$138K Buy
+5,138
New +$167K 0.01% 624

Other funds holding VIR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GP
GSK plc London $602M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Leonteq Securities AG's VIR Position: Q2 2026 in Review

Leonteq Securities AG opened a new position in Vir Biotechnology (VIR) in Q2 2026: 20,000 shares worth $204K. The stake represents 0.01% of the portfolio and ranks #566 among its holdings. This is a return to the name: Leonteq Securities AG previously reported a position in VIR as recently as Q2 2025.

Leonteq Securities AG first reported a position in VIR in Q4 2020 and has held it in 20 quarters since. The position peaked at $1.49M in Q1 2023. 237 funds tracked by Wall St. Rank hold VIR as of Q2 2026.

  • Leonteq Securities AG held 20,000 shares of Vir Biotechnology worth $204K as of Q2 2026.
  • Vir Biotechnology was a new Leonteq Securities AG position in Q2 2026.
  • Vir Biotechnology made up 0.01% of Leonteq Securities AG's portfolio in Q2 2026, its #566 holding.
  • Leonteq Securities AG first reported a position in Vir Biotechnology in Q4 2020 and has held it in 20 quarters since.
  • Leonteq Securities AG's Vir Biotechnology position peaked at $1.49M in Q1 2023.
  • 237 funds tracked by Wall St. Rank held Vir Biotechnology as of Q2 2026.

Based on Leonteq Securities AG's 13F filing for Q2 2026, filed 27 Jul 2026.